Enlitic

ASX-ENL
Australian Securities Exchange
Healthcare Health Information Services
Global Rank
#48443
Country Rank
#5810
Market Cap
2.41 M
Price
0.00289
Change (%)
0.00%
Volume
19.08 M

Enlitic's latest marketcap:

2.41 M

As of 09/08/2026, Enlitic's market capitalization has reached $2.41 M. According to our data, Enlitic is the 48443th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 2.41 M
Revenue (ttm) 3.75 M
Net Income (ttm) -14,027,939.03
Shares Out 833.18 M
EPS (ttm) -0.02
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 09/10/2026
Market Cap Chart
Data Updated: 09/08/2026

Enlitic's yearly market capitalization.

Enlitic has seen its market value drop from A$74.2 M to A$3.33 M since 2023, representing a total decrease of 95.51% and an annual compound decline rate (CAGR) of 68.37%.
Date Market Cap(A$) Market Cap(USD) Change (%) Global Rank
09/08/2026 A$3.33 M $2.41 M -75% 48443
12/31/2025 A$15 M $9.81 M -57.14% 38103
12/31/2024 A$34.99 M $21.65 M -52.85% 33685
12/29/2023 A$74.2 M $50.51 M 27691

Company Profile

About Enlitic, Inc.

Enlitic, Inc. is a healthcare technology company specializing in AI-driven solutions for medical imaging data management. Operating in the United States, Europe, and Japan, Enlitic develops innovative software products designed to enhance radiology workflows and improve patient care.

Core Offerings

Enlitic's AI-powered solutions include:

  • ENDEX: A platform leveraging artificial intelligence to standardize medical imaging data.
  • ENCOG: An AI-enabled data anonymization solution that safeguards protected health information while preserving clinical relevance in medical imaging studies.
  • Migratek: An AI-driven data migration solution with routing services.

Target Markets

The company serves a diverse range of healthcare stakeholders, including:

  • Healthcare IT professionals
  • Hospital executives
  • Clinical researchers

Company Background

Originally founded as You Partners, Inc., the company rebranded as Enlitic, Inc. in 2014. Headquartered in Fort Collins, Colorado, Enlitic continues to pioneer AI applications in medical imaging and healthcare data management.

Frequently Asked Questions

  • What is Enlitic's (ASX-ENL) current market cap?
    As of 09/08/2026, Enlitic (including the parent company, if applicable) has an estimated market capitalization of $2.41 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Enlitic global market capitalization ranking is approximately 48443 as of 09/08/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.